A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa
Condition: X-Linked Retinitis Pigmentosa Intervention: Genetic: AAV5-hRKp.RPGR Sponsor: Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials
A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of INS1007 in Healthy Japanese and Caucasian Participants
Condition: Healthy Volunteers Interventions: Drug: INS1007; Drug: Placebo Sponsor: Insmed Incorporated Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials
A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa
Condition: X-Linked Retinitis Pigmentosa Intervention: Genetic: AAV5-hRKp.RPGR Sponsor: Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials
A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of INS1007 in Healthy Japanese and Caucasian Participants
Condition: Healthy Volunteers Interventions: Drug: INS1007; Drug: Placebo Sponsor: Insmed Incorporated Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials
A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa
Condition: X-Linked Retinitis Pigmentosa Intervention: Genetic: AAV5-hRKp.RPGR Sponsor: Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials
A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of INS1007 in Healthy Japanese and Caucasian Participants
Condition: Healthy Volunteers Interventions: Drug: INS1007; Drug: Placebo Sponsor: Insmed Incorporated Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials
A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa
Condition: X-Linked Retinitis Pigmentosa Intervention: Genetic: AAV5-hRKp.RPGR Sponsor: Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials
A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of INS1007 in Healthy Japanese and Caucasian Participants
Condition: Healthy Volunteers Interventions: Drug: INS1007; Drug: Placebo Sponsor: Insmed Incorporated Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials